Profile
DRIO DHR-PB TMO DHR A IDXX
Company Name DarioHealth Corp. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation Agilent Technologies, Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $56.85M $916.76B $227.24B $196.87B $45.20B $44.88B
Employees 0.28K 79.00K 122.00K 61.00K 17.70K 11.00K
CEO Mr. Erez Raphael Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Henrik Ancher-Jensen Mr. Jonathan J. Mazelsky
Ratings
Trading
DRIO DHR-PB TMO DHR A IDXX
Last Close $1.9 $1261.26 $595.3 $265.8 $154.23 $543.45
High 52 $4.33 $1261.26 $599.43 $265.8 $154.31 $576.87
Low 52 $1 $1261.26 $431.41 $185.1 $101.17 $391.37
Price vs. 52 Week High -56.12 % 0 % -0.69 % 0 % -0.05 % -5.79 %
Price vs. 52 Week Low 90 % 0 % 37.99 % 43.6 % 52.45 % 38.86 %
Total Return
DRIO DHR-PB TMO DHR A IDXX
1 Month Return 65.22 % 0 % 9.93 % 12.46 % 16.45 % 13.74 %
3 Month Return -19.15 % 0 % 8.66 % 6.32 % 14.38 % -2.18 %
6 Month Return 59.66 % 0 % 27.63 % 27.92 % 36.31 % 17.2 %
9 Month Return -32.26 % 0 % 11.82 % 5.72 % 29.33 % 12.35 %
YTD Return 10.47 % 0 % 12.15 % 14.9 % 10.93 % -2.09 %
1 Year Return -49.6 % 0 % 13.71 % 17.39 % 19.43 % 10.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DRIO DHR-PB TMO DHR A IDXX
Dividend Yield Percentage (TTM) - 0.38 % 0.24 % 0.38 % 0.6 % -
Dividend Paid and Capex Coverage Ration (TTM) -68.43 % 3.16 % 4.68 % 2.65 % 3.39 % 7.41 %
Dividend Per Share (TTM) - 1.02 % 1.44 % 1.02 % 0.92 % -
Payout Ratio (TTM) - 17.87 % 8.97 % 27.74 % 21.6 % -
Growth
DRIO DHR-PB TMO DHR A IDXX
Asset Growth -19.13 % 0.16 % 1.62 % 0.16 % 2.35 % 18.68 %
Gross Profit Growth -38.02 % -25.94 % -21.93 % -25.94 % -6.9 % 9.26 %
Revenue Growth -26.41 % -24.09 % -4.58 % -24.09 % -0.22 % 8.72 %
Revenue 3 Year -43.54 % 2.8 % 36.47 % 2.8 % 34.51 % 38.96 %
Revenue 5 Year -88.64 % 14.24 % 83.24 % 14.24 % 51.82 % 72.97 %
Revenue 10 Year - 18.09 % 205.6 % 18.09 % 16.86 % 240.27 %
EBIT Growth 1.32 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Net Income Growth 11.79 % -33.92 % -13.74 % -33.92 % -1.12 % 24.44 %
Net Income 3 Yeari Growth Per Share 60.22 % 25.29 % -3.52 % 25.29 % 81.26 % 49.23 %
Net Income 5 Yeari Growth Per Share 87.29 % 70.95 % 112.51 % 70.95 % 328.44 % 134.38 %
Net Income 10 Yeari Growth Per Share 99.86 % 67.05 % 339.48 % 67.05 % 98.65 % 475.93 %
Operating Income Growth 1.32 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Operating Cash Flow Growth (CFG) 36.51 % -15.91 % -8.17 % -15.91 % 35.06 % 66.95 %
Operating 3 Year CFG 64 % 10.65 % 4.04 % 10.65 % 102.22 % 43.71 %
Operating 5 Year CFG 89.07 % 69.44 % 92.7 % 69.44 % 77.99 % 136.94 %
Operating 10 Year CFG 99.86 % 88.83 % 290.23 % 88.83 % 78.41 % 371.66 %
EPS Growth 26.62 % -34.29 % -12.41 % -34.29 % 0.72 % 25.25 %
EPS Diluted Growth 26.62 % -33.82 % -12.41 % -33.82 % 0.24 % 25.28 %
Book Value Per Share -39.45 % 5.14 % 7.9 % 5.14 % 12.39 % 145.51 %
Share Holder 3 Year Equity Growth Per Share -56.59 % 28.97 % 38.91 % 28.97 % 26.07 % 141.3 %
Share Holder 5 Year Equity Growth Per Share -73.12 % 80.33 % 76.4 % 80.33 % 39.74 % 16418.79 %
Share Holder 10 Year Equity Growth Per Share 124.14 % 125.79 % 158.74 % 125.79 % 28.25 % 266.68 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % 7.8 % -
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % 25.46 % -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % 97.03 % -
Debt Growth 5.32 % -0.72 % 1.24 % -0.72 % -1.23 % -29.7 %
Free Cash Flow Growth 36.05 % -21.53 % 0.23 % -21.53 % 44.37 % 96.09 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023 31 Dec 2023
Profitability
DRIO DHR-PB TMO DHR A IDXX
Gross Profit Margin TTM 27.56 % 58.45 % 41.2 % 58.4 % 50.63 % 60.14 %
Return on Assets TTM -13.58 % 5.33 % 6.21 % 5.28 % 11.29 % 25.84 %
Return on Equity TTM -26.32 % 8.42 % 13.31 % 8.34 % 21.15 % 63.66 %
Return on Capital Employed TTM -51.12 % 7.39 % 8.44 % 5.54 % 14.19 % 46.55 %
Net Income Per EBT TTM 80.62 % 83.98 % 92.49 % 97.45 % 92.79 % 79.58 %
EBT Per Ebit TTM 37.87 % 94.74 % 92.99 % 107.86 % 100.6 % 97.61 %
EBIT Per Revenue TTM -319.86 % 21.3 % 16.51 % 18.6 % 19.66 % 29.95 %
Cash Flow To Debt Ratio TTM -131.82 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Receivables Turnover TTM 2.42 7.76 4.54 6.66 5.2 6.44
Payables Turnover TTM 3.25 6.49 9.78 5.58 6.81 12.64
Inventory Turnover TTM 2.81 4.12 4.87 3.54 3.22 3.8
Fixed Asset Turnover TTM 588.14 % 463.28 % 455.73 % 397.72 % 458.48 % 449.53 %
Asset Turnover TTM 13.9 % 31.45 % 43.76 % 27 % 61.52 % 111.07 %
Operating Cash Flow Per Share TTM -1.12 9.27 23.37 9.39 6.69 11.09
Free Cash Flow Per Share TTM -1.14 7.39 19.79 7.5 5.63 9.59
Cash Per Share TTM 102.6 % 937.04 % 1899.74 % 949.37 % 596.59 % 478.28 %
Operating Cash Flow Sales Ratio TTM -203.38 % 26.52 % 21.01 % 30.89 % 29.12 % 24.73 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.46 % 79.76 % 84.68 % 79.89 % 84.09 % 86.5 %
Cash Flow Coverage Ratios TTM -131.82 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Price To Free Cash Flows Ratio TTM -1.45 35.49 30.06 35.43 27.41 56.33
Price To Operating Cash Flows Ratio TTM -1.69 28.67 25.47 28.3 23.04 49.02
Price Cash Flow Ratio TTM -1.69 28.67 25.47 28.3 23.04 49.02
Income Statement (TTM)
DRIO DHR-PB TMO DHR A IDXX
Revenue $0.02B $23.89B $42.86B $23.89B $6.83B $3.66B
Gross Profit $0.01B $14.03B $15.22B $14.03B $3.47B $2.19B
Gross Profit Ratio 29.4% 58.74% 35.52% 58.74% 50.71% 59.82%
EBITDA $-0.05B $7.76B $10.72B $7.76B $1.71B $1.1B
Net Income $-0.05B $4.76B $6B $4.76B $1.24B $0.85B
EPS Diluted -1.93 6.38 15.45 6.38 4.19 10.06
Balance Sheet (MRQ)
DRIO DHR-PB TMO DHR A IDXX
Long Term Debt $0.02B $17.66B $31.31B $17.66B $2.74B $0.62B
Total Liabilities $0.04B $31B $51.88B $31B $4.92B $1.78B
Total Equity $0.06B $53.49B $46.84B $53.49B $5.85B $1.48B
Total Investments $0B $0.01B $-1.92B $0.01B $0.16B $0.06B
Total Debt $0.03B $19.54B $34.92B $19.54B $2.74B $0.95B
Total Assets $0.1B $84.49B $98.73B $84.49B $10.76B $3.26B
Cash Flow Statement (TTM)
DRIO DHR-PB TMO DHR A IDXX
Net Income $-0.05B $4.22B $6B $4.22B $1.24B $0.85B
Inventory $0B $0.19B $0.6B $0.19B $-0.03B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $-0.27B $0B
Operating Cash Flow $-0.03B $7.16B $8.41B $7.16B $1.77B $0.91B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.3B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 154.23
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 2.51
AWH Aspira Women's Health Inc. 2.66
BDSX Biodesix, Inc. 1.575
BIAF bioAffinity Technologies, Inc. 2.26
BIAFW bioAffinity Technologies, Inc. 0.32
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 1.14
BNR Burning Rock Biotech Limited 8.3
CDNA CareDx, Inc 15.5
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.185
CNTG Centogene N.V. 0.37
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 221.61
CSTL Castle Biosciences, Inc. 24.24
DGX Quest Diagnostics Incorporated 144.34
DHR Danaher Corporation 265.8
ETFs With Exposure to DRIO
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 173.42
IWC iShares Micro-Cap ETF 0.01009 119.09
VFLQ Vanguard U.S. Liquidity Factor ETF 0.02 99.7611
DFAT Dimensional U.S. Targeted Value ETF 0.00011686 54.33
DFAS Dimensional U.S. Small Cap ETF 0.00017897 62.04
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.58
DFSU Dimensional US Sustainability Core 1 ETF 0.000003 34.37
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000197721 89.84
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.58
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
DCOR Dimensional ETF Trust 0.00000483 58.89
VEMPX Vanguard Extended Market Index InstlPlus 0 324.71
Unlock